Exec-Edge, Author at ExecEdge - Page 13 of 139

Imviva’s CTA313 Lupus Drug Shows Promising Remission Results

Imviva’s CTA313 Lupus Drug Shows Promising Remission Results

By Daniella Parra Imviva Biotech said data showed its CTA313 drug resulted in 50% of patients going into remission for systemic lupus. Many patients experience incomplete responses, recurrent flares and long-term treatment-related toxicity, it said. “The clinical activity observed with...

Input your search keywords and press Enter.